US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Recruiting clinical trials with at least one study location in Wisconsin. Data updated daily from ClinicalTrials.gov.

Total Trials
175
Recruiting Now
175
← Back to US Map
Top Conditions in Wisconsin
Breast Cancer (7)Endometrial Cancer (5)Colorectal Cancer (4)Prostate Cancer (4)Advanced Solid Tumors (3)Advanced Solid Tumor (3)Ovarian Cancer (3)Healthy Participants (3)Pulmonary Embolism (2)Falls-Risk (2)Pancreatic Ductal Adenocarcinoma (2)Stroke (2)
NCT05083481 Phase 1, Phase 2
Recruiting
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembro...
Condition
Advanced Solid Tumors
Enrollment
366 pts
Location
United States, China, France
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT06299592 N/A
Recruiting
Comparison of Microglial Activation in Severe Asthma and Healthy Controls
Condition
Asthma
Enrollment
100 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT05742607 Phase 2
Recruiting
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (M...
Condition
Non Small Cell Lung Cancer
Enrollment
70 pts
Location
United States, France, Greece
Sponsor
Innate Pharma
View Trial →
NCT01915511 N/A
Recruiting
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes...
Condition
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Enrollment
3,000 pts
Location
United States
Sponsor
Duke University
View Trial →
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04736667 N/A
Recruiting
Mitral Valve Screening Survey
Condition
Mitral Valve Disease
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Medstar Health Research Instit
View Trial →
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Czechia
Sponsor
Merz Therapeutics GmbH
View Trial →
NCT07390136 N/A
Recruiting
Sparking Potential, Revealing Infant Neurocognitive Traits
Condition
Perinatal Brain Injury
Enrollment
200 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT02012699 N/A
Recruiting
Integrated Cancer Repository for Cancer Research
Condition
Pancreatic Cancer
Enrollment
999,999 pts
Location
United States
Sponsor
University of Nebraska
View Trial →
NCT06608511 N/A
Recruiting
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
Condition
Skin Cancer
Enrollment
20 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT05254171 Phase 2, Phase 3
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Ca...
Condition
Pancreatic Cancer Metastatic
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Panbela Therapeutics, Inc.
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05914987 N/A
Recruiting
Determining Individualized Cancer Therapy in Pancreatic Cancer
Condition
Pancreatic Neoplasms
Enrollment
1,000 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT06505187 Phase 2
Recruiting
Celecoxib for ENT Pain Management
Condition
Parotidectomy
Enrollment
84 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06388421 N/A
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension As...
Condition
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment
1,000 pts
Location
United States, Puerto Rico
Sponsor
United Therapeutics
View Trial →
NCT05846685 N/A
Recruiting
Patient Perspectives of an Automated Falls-Risk Screening and Referral Tool in t...
Condition
Falls-Risk
Enrollment
174 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06495710 N/A
Recruiting
Arterial Stiffness and Blood Pressure
Condition
Hypertension
Enrollment
228 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06087224 N/A
Recruiting
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Res...
Condition
Death; Neonatal
Enrollment
947 pts
Location
United States, Canada
Sponsor
Mayo Clinic
View Trial →
NCT06788652 N/A
Recruiting
A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With L...
Condition
Mantle Cell Lymphoma (MCL)
Enrollment
300 pts
Location
United States
Sponsor
Juno Therapeutics, Inc., a Bri
View Trial →
NCT05985681 Phase 1
Recruiting
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
Condition
Human Papillomavirus-Related Carcinoma
Enrollment
18 pts
Location
United States, Austria
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
View Trial →
NCT05919264 Phase 1, Phase 2
Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Condition
Cancer
Enrollment
575 pts
Location
United States
Sponsor
Parabilis Medicines, Inc.
View Trial →
NCT06076304 Phase 4
Recruiting
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effecti...
Condition
Sinus Infection
Enrollment
3,720 pts
Location
United States
Sponsor
Daniel Merenstein
View Trial →
NCT06258447 N/A
Recruiting
CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Re...
Condition
Ischemic Heart Failure
Enrollment
250 pts
Location
United States
Sponsor
BioCardia, Inc.
View Trial →
NCT06050252 Phase 2
Recruiting
Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resecta...
Condition
Resectable Intrahepatic Cholangiocarcinoma
Enrollment
27 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
Page 7 of 7 — 175 trials total
← Prev